Some protocols add GHK-Cu for additional tissue remodeling and anti-aging effects
The six peptides are not currently listed in 21 CFR 216.23, the FDA has not issued a final determination, and none became an FDA-approved drug because of the vote
Lila 2.0 Supersonic Rich Ortiz #PeptideUpdate #FDA #InjectableDecade #GLP-1 #ZheroRestarts To view or add a comment, sign in The FDAs Pharmacy Compounding Advisory Committee (PCAC) is meeting today and tomorrow (July 23-24) to review several high-profile peptide injections, including BPC-157, TB-500, KPV, MOTS-C, and others, as well as vote on whether compounding pharmacies should be permitted to dispense them
Can BPC-157 help with old scars
That can translate into less inflammation, less scar tissue, and more long-term well-being
The platform's resources help users avoid common mistakes and optimize results throughout their copper peptide journey